Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
MIAMI--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most ...
BOSTON, Mass. - July 27, 2016 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...
Clinical Experience with Penumbra JET™ 7 Reperfusion Catheter with XTRA FLEX Technology to be Highlighted at Company-Sponsored Symposium MIAMI--(BUSINESS WIRE)-- Penumbra, Inc. (NYSE: PEN), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results